PFM Health Sciences, LP 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-21 4:02 pm Purchase | 2025-02-13 | 13G | PMV Pharmaceuticals, Inc. PMVP | PFM Health Sciences, LP | 2,598,827 5.000% | 2,598,827 (New Position) | Filing |